FFCP PHASE1:Mm9::chr17:74366338..74366346,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=146|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr17:74366338..74366346,-|id=chr17:74366338..74366346,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002369!3.13e-12!7;UBERON:0006858!3.13e-12!7;UBERON:0003064!1.11e-10!14;UBERON:0002342!9.68e-09!10;UBERON:0005062!9.68e-09!10;UBERON:0000489!5.50e-07!21|ontology_enrichment_uberon_v019_2=UBERON:0003064,1.36e-19,14;UBERON:0002369,1.31e-17,7;UBERON:0006858,1.31e-17,7;UBERON:0001301,5.71e-11,3;UBERON:0006555,5.71e-11,3;UBERON:0005103,5.71e-11,3;UBERON:0000083,5.71e-11,3;UBERON:0009201,5.71e-11,3;UBERON:0004819,5.71e-11,3;UBERON:0006553,5.71e-11,3;UBERON:0003074,5.71e-11,3;UBERON:0003060,5.71e-11,3;UBERON:0000080,1.46e-08,4;UBERON:0005904,1.46e-08,4;UBERON:0006947,1.46e-08,4;UBERON:0002120,1.46e-08,4;UBERON:0004054,1.46e-08,4;UBERON:0004875,1.46e-08,4;UBERON:0004876,1.46e-08,4;UBERON:0005721,1.46e-08,4;UBERON:0005754,1.46e-08,4;UBERON:0007297,1.46e-08,4;UBERON:0005256,8.07e-07,45|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.142371680799103,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.49235914539852,0,0,0,0,0.23517741427141,1.0053327306374,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.26361379216837,0,0,0,0,0,0,0,0,0.258703370739016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0701358198903186,0,0,0.156998727841375,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.141940085208269,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.120625849856312,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr17:74366338..74366346,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=146 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr17:74366338..74366346,- | |||
|description=CAGE_peak_at_chr17:74366338..74366346,- | |||
|id=chr17:74366338..74366346,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002369!3.13e-12!7;UBERON:0006858!3.13e-12!7;UBERON:0003064!1.11e-10!14;UBERON:0002342!9.68e-09!10;UBERON:0005062!9.68e-09!10;UBERON:0000489!5.50e-07!21 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0003064,1.36e-19,14;UBERON:0002369,1.31e-17,7;UBERON:0006858,1.31e-17,7;UBERON:0001301,5.71e-11,3;UBERON:0006555,5.71e-11,3;UBERON:0005103,5.71e-11,3;UBERON:0000083,5.71e-11,3;UBERON:0009201,5.71e-11,3;UBERON:0004819,5.71e-11,3;UBERON:0006553,5.71e-11,3;UBERON:0003074,5.71e-11,3;UBERON:0003060,5.71e-11,3;UBERON:0000080,1.46e-08,4;UBERON:0005904,1.46e-08,4;UBERON:0006947,1.46e-08,4;UBERON:0002120,1.46e-08,4;UBERON:0004054,1.46e-08,4;UBERON:0004875,1.46e-08,4;UBERON:0004876,1.46e-08,4;UBERON:0005721,1.46e-08,4;UBERON:0005754,1.46e-08,4;UBERON:0007297,1.46e-08,4;UBERON:0005256,8.07e-07,45 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.142371680799103,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.49235914539852,0,0,0,0,0.23517741427141,1.0053327306374,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.26361379216837,0,0,0,0,0,0,0,0,0.258703370739016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0701358198903186,0,0,0.156998727841375,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.141940085208269,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.120625849856312,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr17:74366338..74366346,- | |||
}} |
Latest revision as of 08:02, 5 August 2015
Short description: | p@chr17:74366338..74366346, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr17:74366338..74366346, - |
Coexpression cluster: | MCL_coexpression_mm9:146 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
intermediate mesoderm | 1.36e-19 | 14 |
adrenal gland | 1.31e-17 | 7 |
adrenal/interrenal gland | 1.31e-17 | 7 |
epididymis | 5.71e-11 | 3 |
excretory tube | 5.71e-11 | 3 |
mesonephric epithelium | 5.71e-11 | 3 |
mesonephric tubule | 5.71e-11 | 3 |
nephric duct | 5.71e-11 | 3 |
kidney epithelium | 5.71e-11 | 3 |
renal duct | 5.71e-11 | 3 |
mesonephric duct | 5.71e-11 | 3 |
pronephric duct | 5.71e-11 | 3 |
mesonephros | 1.46e-08 | 4 |
duct of male reproductive system | 1.46e-08 | 4 |
male genital duct | 1.46e-08 | 4 |
pronephros | 1.46e-08 | 4 |
internal male genitalia | 1.46e-08 | 4 |
nephrogenic cord | 1.46e-08 | 4 |
urogenital ridge | 1.46e-08 | 4 |
pronephric mesoderm | 1.46e-08 | 4 |
rostral part of nephrogenic cord | 1.46e-08 | 4 |
presumptive pronephric mesoderm | 1.46e-08 | 4 |
trunk mesenchyme | 8.07e-07 | 45 |